Myorhythmia: Phenomenology, etiology, and treatment

Movement Disorders

Volumn 30, Issue 2, 2015, Pages 171-179

  Baizabal Carvallo, José Fidel ^a   Cardoso, Francisco ^b   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Movement disorders; Myorhythmia; Slow tremor; Stroke; Whipple's disease

Indexed keywords

BACLOFEN; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CEFTRIAXONE; CHLORAMPHENICOL; CLONAZEPAM; CORTICOSTEROID; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; HALOPERIDOL; IMMUNOGLOBULIN; LEVODOPA; LORAZEPAM; PROPRANOLOL; RITUXIMAB; SULFADIAZINE; SULFAMETHOXAZOLE; TETRABENAZINE; TETRACYCLINE; TRIHEXYPHENIDYL; VALPROIC ACID; VIGABATRIN;

ANTIBIOTIC THERAPY; AUTOIMMUNE DISEASE; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; BRAIN STEM TUMOR; CENTRAL NERVOUS SYSTEM INFECTION; CEREBELLUM DEGENERATION; CEREBROVASCULAR DISEASE; CHEMOTHERAPY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ELECTROMYOGRAPHY; FLAPPING TREMOR; GILLES DE LA TOURETTE SYNDROME; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOTHERAPY; INTESTINE LIPODYSTROPHY; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; MYOCLONUS; MYOKYMIA; NEOPLASM; OCULO MASTICATORY MYORHYTHMIA; PARKINSON DISEASE; PATHOGENESIS; PHENOMENOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; TIC; TREMOR; ANIMAL; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; COMPLICATION; MOVEMENT DISORDERS; STROKE; WHIPPLE DISEASE;

ANIMALS; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; HUMANS; MOVEMENT DISORDERS; MULTIPLE SCLEROSIS; STROKE; TREMOR; WHIPPLE DISEASE;

EID: 84922231585     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26093     Document Type: Review

References (110)

1. Fahn S, Jankovic J, Hallett M. Principles and Practice of Movement Disorders. Philadelphia, PA, USA: Churchill Livingstone, Elsevier, 2011:1-548.
2. Lee MS, Kim YD, Kim WC, Lyoo CH. Slow rhythmic dyskinesia of the shoulder: one idiopathic and two symptomatic cases. Mov Disord 1999;14:1049-1051.
3. Herz E. Die amyostatischen Unruheerscheinungen. Klinisch kinematographische Analyse ihrer Kennzeichen und Beleiterscheinungen. J Psychol Neurol 1931;43:146-163.
4. Guillain G, Mollaret P. Deux cas de myoclonies synchrones et rythmées vélo-pharyngo-laryngo-oculo-diaphragmatiques. Le problème anatomique et physio-pathologique de ce syndrome. Rev Neurol 1931;2:545-566.
5. Foix CH, Chavany JA, Hillemand P. Le syndrome myoclonique de la calotte. Étude anatomo-clinique du nystagmus du voile et des myoclonies rythmiques associées oculaires, faciales, etc. Rev Neurol 1926;1:942-956.
6. Guillain G, Thurel R. Myoclonies vélo-pharyngo-laryngo-oculo-diaphragmatiques associées à des myoclonies synchrones squelettiques. Rev Neurol 1932;2:677-684.
7. Guillain G, Thurel R, Bertrand I. Examen anatomo-pathologique d'un cas de myoclonies vélo-pharyngo-oculo-diaphragmatiques associées a des myoclonies squelettiques synchrones. Rev Neurol 1933;2:801-812.
8. Guillain G, Bertrand I, Lereboullet J. Myoclonies arythimiques unilatérales des membres par lésion du noyau dentelé du cervelet. Rev Neurol 1934;2:73-78.
9. Garcin R, Lapresle J, Fardeau M. Rhythmic skeletal myoclonus without nystagmus of the velum: anatomo-clinical study with presentation of a cinematographic film. Rev Neurol (Paris) 1963;109:105-114.
10. Rondot P, Ben Hamida M. Myoclonus of the velum and skeletal myoclonus: clinical and anatomical study. Rev Neurol (Paris) 1968;l19:59-83.
11. Crouzon O, Christophe J. Syndrome pseudo-bulbaire et cérébelleux d'origine protubérantielle avec myoclonies rhythmiques et synchrones vélo-pharyngo-facio-laryngées bilatérales et myoclonies oculaires et squelettiques unilatérales. Rev Neurol 1936;65:76-81.
12. De Savitsch E. Étude anatomique d'un cas de myoclonies vélo-palato-laryngées avec nystagmus myoclonique rotatoire. J Belge Neurol Psychiatr 1936;36:291-297.
13. Lhermitte J, Sigwald J. Myoclonies rythmées du voile du pharynx, du larynx et du membre supérieur gauche au cours d'un syndrome latéral du bulbe. Rev Neurol 1941;73:81-86.
14. Silfverskiold BP. Rhythmic myoclonias including spinal myoclonus. Adv Neurol 1988;43:275-285.
15. Masucci EF, Kurtzke JF, Saini N. Myorhythmia: a widespread movement disorder: clinico pathological correlations. Brain 1984;107:53-79.
16. Dimberg EL, Crowe SE, Trugman JM, et al. Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasm. Mov Disord 2007;22:407-411.
17. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorders Society on tremor. Ad Hoc Scientific Committee. Mov Disord 1998;13(Suppl 4):2-23.
18. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:863-873.
19. Erro R, Rubio-Agusti I, Saifee TA, Cordivari C, Ganos C, Batla A, Bhatia KP. Rest and other types of tremor in adult-onset primary dystonia. J Neurol Neurosurg Psychiatry 2014;85:965-968.
20. Fasano A, Bove F, Lang AE. The treatment of dystonic tremor: a systematic review. J Neurol Neurosurg Psychiatry 2014;85:759-769.
21. Bain PG. Dystonic tremor presenting as parkinsonism: long-term follow-up of SWEDDs. Neurology 2009;72:1443-1445.
22. Schwingenschuh P, Ruge D, Edwards MJ, et al. Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov Disord 2010;25:560-569.
23. Shepherd GM, Tauböll E, Bakke SJ, Nyberg-Hansen R. Midbrain tremor and hypertrophic olivary degeneration after pontine hemorrhage. Mov Disord 1997;12:432-437.
24. Yang YW, Chang FC, Tsai CH, et al. Clinical and magnetic resonance imaging manifestations of Holmes tremor. Acta Neurol Taiwan 2005;14:9-15.
25. Jankovic J, Pardo R. Segmental myoclonus: clinical and pharmacologic study. Arch Neurol 1986;43:1025-1031.
26. Birbamer G, Gerstenbrand F, Aichner F, et al. MR-imaging of post-traumatic olivary hypertrophy. Funct Neurol 1994;9:183-187.
27. Yoshikawa H, Takamori M. Benign segmental myoclonus: electrophysiological evidence of transient dysfunction in the brainstem. J Clin Neurosci 2001;8:54-56.
28. Marrufo M, Politsky J, Mehta S, Morgan JC, Sethi KD. Paroxysmal kinesigenic segmental myoclonus due to a spinal cord glioma. Mov Disord 2007;22:1801-1803.
29. Tyvaert L, Krystkowiak P, Cassim F, et al. Myoclonus of peripheral origin: two case reports. Mov Disord 2009;24:274-277.
30. van Rootselar AF, van Schaik IN, van den Maagdenberg AM, et al. Familial cortical myoclonic tremor with epilepsy: a single syndromic classification for a group of pedigrees bearing common features. Mov Disord 2005;20:665-673.
31. De Fusco M, Vago R, Striano P, et al. The α2B -adrenergic receptor is mutant in cortical myoclonus and epilepsy. Ann Neurol 2014;75:77-87.
32. Crompton DE, Sadleir LG, Bromhead CJ, et al. Familial adult myoclonic epilepsy: recognition of mild phenotypes and refinement of the 2q locus. Arch Neurol 2012;69:474-481.
33. Browner N, Azher SN, Jankovic J. Botulinum toxin treatment of facial myoclonus in suspected Rasmussen encephalitis. Mov Disord 2006;21:1500-1502.
34. Dibbens LM, Michelucci R, Gambardella A, et al. SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure. Ann Neurol 2009;66:532-536.
35. Rubboli G, Franceschetti S, Berkovic SF, et al. Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations. Epilepsia 2011;52:2356-2363.
36. Elble R, Deuschl G. Milestones in tremor research. Mov Disord 2011;26:1096-1105.
37. Deuschl G, Toro C, Valls-Solé J, Zeffiro T, Zee DS, Hallet M. Symptomatic and essential palatal tremor. 1. Clinical, physiological and MRI analysis. Brain 1994;117:775-788.
38. Borruat FX. Oculopalatal tremor: current concepts and new observations. Curr Opin Neurol 2013;26:67-73.
39. Kim JS, Moon SY, Choi KD, Kim JH, Sharpe JA. Patterns of ocular oscillation in oculopalatal tremor: imaging correlations. Neurology 2007;68:1128-1135.
40. Galvez-Ruiz A, Roig C, Muñoz S, Arruga J. Convergent-divergent nystagmus as a manifestation of oculopalatal tremor. Neuro-Ophthalmology 2011;35:276-279.
41. Shaikh AG, Hong S, Liao K, et al. Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity. Brain 2010;133:923-940.
42. Louis ED, Babij R, Cortés E, Vonsattel JP, Faust PL. The inferior olivary nucleus: a postmortem study of essential tremor cases versus controls. Mov Disord 2013;28:779-786.
43. Van Der Giessen RS, Koekkoek SK, Van Dorp S, et al. Role of olivary electrical coupling in cerebellar motor learning. Neuron 2008;58:599-612.
44. Rekling JC, Jensen KH, Jahnsen H. Spontaneous cluster activity in the inferior olivary nucleus in brainstem slices from postnatal mice. J Physiol 2012;590:1547-1562.
45. Masucci E, Kurtzke J. Palatal myoclonus associated with extremity tremor. J Neurol 1989;236:474-477.
46. Yanagisawa T, Sugihara H, Shibahara K, Kamo T, Fujisawa K, Murayama M. Natural course of combined limb and palatal tremor caused by cerebellar-brain stem infarction. Mov Disord 1999;14:851-854.
47. Shaikh AG, Thurtell MJ, Optican LM, Leigh RJ. Pharmacological tests of hypotheses for acquired pendular nystagmus. Ann NY Acad Sci 2011;1233:320-326.
48. Wang D, Sanchez J, Foote KD, et al. Failed DBS for palliation of visual problems in a case of oculopalatal tremor. Parkinsonism Relat Disord 2009;15:71-73.
49. Yaltho TC, Jankovic J. The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord 2011;26:1582-1592.
50. Fernandez M, Raskind W, Wolff J, et al. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder. Ann Neurol 2001;49:486-492.
51. Chen YZ, Matsushita MM, Robertson P, et al. Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5. Arch Neurol 2012;69:630-635.
52. Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord 2011;26:1149-1156.
53. Schwartz M, Hocherman S. Antipsychotic-induced rabbit syndrome: epidemiology, management and pathophysiology. CNS Drugs 2004;18:213-220.
54. Tan EK, Chan LL, Lo YL. Myorhythmia slow facial tremor from chronic interferon alpha-2a usage. Neurology 2003;61:1302-1303.
55. Shuto H, Kataoka Y, Horikawa T, Fujihara N, Oishi R. Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 1997;747:348-351.
56. van Meerbeeck PC, Fénelon G, Ahdab R, Lefaucheur JP. Electrophysiological assessment of a case of limb myorhythmia. Clin Neurophysiol 2010;121:2180-2183.
57. Simpson DA, Wishnow R, Gargulinski RB, Pawlak AM. Oculofacial-skeletal myorhythmia in central nervous system Whipple's disease: additional case and review of the literature. Mov Disord 1995;10:195-200.
58. Wu JC, Lu CS, Ng SH. Limb myorhythmia in association with hypertrophy of the inferior olive: report of two cases. Chang Gung Med J 2000;23:630-635.
59. Matsuo F, Ajax ET. Palatal myoclonus and denervation super sensitivity in the central nervous system. Ann Neurol 1979;5:72-78.
60. Lera G, Scipioni O, Garcia S, Cammarota A, Fischbein G, Gershanik O. A combined pattern of movement disorders resulting from posterolateral thalamic lesions of a vascular nature: a syndrome with clinico-radiologic correlation. Mov Disord 2000;15:120-126.
61. Park KI, Chung JM, Lee SH, Lee HK. Myorhythmia associated with listerial rhombencephalitis. Mov Disord 2010;25:950-952.
62. van Bogaert, L, Lafon, R, Pages, P, Labauge, R. Sur une encéphalite subaiguë non classable, principalement caractérisée par des myorhythmies oculo-facio-cervicales. Rev Neurol 1963;109:443.
63. De Jonghe P, Martin JJ, Budka H, Ceuterick C. Cerebral manifestations of Whipple's disease. Acta Neurol Belg 1979;79:305-313.
64. Knox DL, Bayless TM, Pitman FE. Neurologic disease in patients with treated Whipple's disease. Acta Neuropathol 1975;33:275-278.
65. Hausser-Hauw C, Roullet E, Robert R, Marteau R. Oculo-facio-skeletal myorhythmia as a cerebral complication of systemic Whipple's disease. Mov Disord 1988;3:179-184.
66. Grotta JC, Pettigrew LC, Schmidt WA, Friedman G, Snatic S. Oculomasticatory myorhythmia. Ann Neurol 1987;22:395-396.
67. Jankovic J. Whipple's disease of the central nervous system in AIDS. N Engl J Med 1986;315:1029-1030.
68. Mohamed W, Neil E, Kupsky WJ, Juhász C, Mittal S, Santhakumar S. Isolated intracranial Whipple's disease: report of a rare case and review of the literature. J Neurol Sci 2011;308:1-8.
69. Tison F, Louvet-Giendaj C, Henry P, Lagueny A, Gaujard E. Permanent bruxism as a manifestation of the oculo-facial syndrome related to systemic Whipple's disease. Mov Disord 1992;7:82-85.
70. Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol 1996;40:561-568.
71. Schwartz MA, Selhorst JB, Ochs AL, et al. Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease. Ann Neurol 1986;20:677-683.
72. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992;327:293-301.
73. Fenollar F, Puéchal X, Raoult D. Whipple's disease. N Engl J Med 2007;356:55-66.
74. Compain C, Sacre K, Puéchal X, et al. Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up. Medicine (Baltimore) 2013;92:324-330.
75. de Andrade DC, Nogueira RC, Lucato LT, et al. Isolated CNS Whipple disease with a variant of oculofacial-skeletal myorhythmia (OFSM). Neurology 2007;69:E12.
76. Revilla FJ, de la Cruz R, Khardori N, Espay AJ. Teaching NeuroImage: Oculomasticatory myorhythmia: pathognomonic phenomenology of Whipple disease. Neurology 2008;70:e25.
77. Calandra-Buonaura G, Provini F, Guaraldi P, et al. Oculomasticatory myorhythmia and agrypnia excitata guide the diagnosis of Whipple disease. Sleep Med 2013;14:1428-1430.
78. Knox DL, Green WR, Troncoso JC, Yardley JH, Hsu J, Zee DS. Cerebral ocular Whipple's disease: a 62-year odyssey from death to diagnosis. Neurology 1995;45:617-625.
79. Lynch T, Fahn S, Louis ED, Odel JG. Oculofacial-skeletal myorhythmia in Whipple's disease. Mov Disord 1997;12:625-626.
80. Rajput AH, McHattie JD. Ophthalmoplegia and leg myorhythmia in Whipple's disease: report of a case. Mov Disord 1997;12:111-114.
81. Adler CH, Galetta SL. Oculo-facial-skeletal myorhythmia in Whipple disease: treatment with ceftriaxone. Ann Intern Med 1990;112:467-469.
82. Black DF, Aksamit AJ, Morris JM. MR imaging of central nervous system Whipple disease: a 15-year review. AJNR Am J Neuroradiol 2010;31:1493-1497.
83. Yu C, Jiang A, Yu Y. Serial Imaging changes of cerebral Whipple's disease: from onset to the end. J Neuroimaging 2007;17:81-83.
84. Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease. Lancet Neurol 2013;12:597-608.
85. Hirono N, Kameyama M, Kobayashi Y, et al. MR demonstration of a unilateral olivary hypertrophy caused by pontine tegmental hematoma. Neuroradiology 1990;32:340-342.
86. Vancaester E, Hemelsoet D, De Letter M, Santens P. Masticatory myorhythmia following pontine hemorrhage. Acta Neurol Belg 2013;113:327-329.
87. Dietrichs E, Heier MS, Nakstad PH. Jaw-opening dystonia presumably caused by a pontine lesion. Mov Disord 2000;15:1026-1028.
88. Scott B, Jankovic J. Delayed-onset progressive movement disorders. Neurology 1996;46:68-74.
89. Quartarone A, Hallett M. Emerging concepts in the physiological basis of dystonia. Mov Disord 2013;28:958-967.
90. Tan EK, Chan LL, Lo YL. Isolated facial myorhythmia. J Neurol Sci 2007;252:36-38.
91. Li JY, Lee CH. Episodic tongue hyperkinesias and alternating limb movements associated with basilar artery ischemia. Mov Disord 2009;24:1249-1251.
92. Postert T, Amoiridis G, Pöhlau D, Hoffmann V, Przuntek H. Episodic undulating hyperkinesias of the tongue associated with brainstem ischemia. Mov Disord 1997;12:619-621.
93. Kim JS. Delayed onset mixed involuntary movements after thalamic stroke: clinical, radiological and pathophysiological findings. Brain 2001;124:299-309.
94. Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord 1994;9:493-507.
95. Vidailhet M, Jedynak C-P, Pollak P, Agid Y. Pathology of symptomatic tremors. Mov Disord 1998;13:49-54.
96. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74.
97. Baizabal-Carvallo JF, Stocco A, Muscal E, Jankovic J. The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord 2013;28:543-547.
98. Kleinig TJ, Thompson PD, Matar W, et al. The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 2008;23:1256-1261.
99. Baizabal-Carvallo JF, Jankovic J. Movement disorders in autoimmune diseases. Mov Disord 2012;27:935-946.
100. Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y) 2013 Jul 12;3. pii: tre-03-161-4138-1.
101. Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011;77:179-189.
102. Erickson JC, Carrasco H, Grimes JB, Jabbari B, Cannard KR. Palatal tremor and myorhythmia in Hashimoto's encephalopathy. Neurology 2002;58:504-505.
103. Dale RC, Church AJ, Surtees RA, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004;127:21-33.
104. Vilensky JA, Goetz CG, Gilman S. Movement disorders associated with encephalitis lethargica: a video compilation. Mov Disord 2006;21:1-8.
105. Blunt SB, Lane RJ, Turjanski N, Perkin GD. Clinical features and management of two cases of encephalitis lethargica. Mov Disord 1997;12:354-359.
106. Wiener V, Honnorat J, Pandolfo M, Kentos A, Manto MU. Myorhythmia associated with Hodgkin's lymphoma. J Neurol 2003;250:1382-1384.
107. Mehanna R, Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. J Neurol Sci 2013;328:1-8.
108. Evidente VG, Advincula J, Esteban R, et al. Phenomenology of "Lubag" or X-linked dystonia-parkinsonism. Mov Disord 2002;17:1271-1277.
109. Jankovic J, Clarence-Smith K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Exp Rev Neurother 2011;11:1509-1523.
110. Penney SE, Bruce IA, Saeed SR. Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature. J Neurol 2006;253:857-860.